Daoyuan Si

551 total citations
38 papers, 355 citations indexed

About

Daoyuan Si is a scholar working on Cardiology and Cardiovascular Medicine, Infectious Diseases and Surgery. According to data from OpenAlex, Daoyuan Si has authored 38 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Cardiology and Cardiovascular Medicine, 8 papers in Infectious Diseases and 8 papers in Surgery. Recurrent topics in Daoyuan Si's work include COVID-19 Clinical Research Studies (8 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Cardiac tumors and thrombi (7 papers). Daoyuan Si is often cited by papers focused on COVID-19 Clinical Research Studies (8 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Cardiac tumors and thrombi (7 papers). Daoyuan Si collaborates with scholars based in China, Canada and United States. Daoyuan Si's co-authors include Ping Yang, Beibei Du, Kumaraswamy Nanthakumar, Stéphane Massé, Zhongfan Zhang, Qian Zhang, Mohammed Ali Azam, Patrick F.H. Lai, Yuquan He and Guohui Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, FEBS Letters and Life Sciences.

In The Last Decade

Daoyuan Si

37 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daoyuan Si China 11 190 74 73 58 42 38 355
Jun‐Yi Luo China 11 79 0.4× 74 1.0× 63 0.9× 64 1.1× 24 0.6× 40 343
Myoung Ju Koh South Korea 9 54 0.3× 59 0.8× 78 1.1× 38 0.7× 25 0.6× 14 412
Shengda Hu China 11 90 0.5× 48 0.6× 81 1.1× 32 0.6× 9 0.2× 17 296
Yafeng Zhou China 12 175 0.9× 117 1.6× 130 1.8× 12 0.2× 19 0.5× 43 420
Christel H. Kamani Switzerland 10 84 0.4× 82 1.1× 110 1.5× 20 0.3× 9 0.2× 24 328
Xiaodong Jing China 12 170 0.9× 187 2.5× 87 1.2× 21 0.4× 16 0.4× 24 394
Jinru Wei China 9 37 0.2× 28 0.4× 123 1.7× 39 0.7× 31 0.7× 15 287
Yubi Lin China 11 230 1.2× 81 1.1× 78 1.1× 11 0.2× 9 0.2× 23 339
V. А. Snezhitskiy Belarus 5 404 2.1× 63 0.9× 123 1.7× 11 0.2× 9 0.2× 54 582
Matthias Hammwöhner Germany 11 338 1.8× 32 0.4× 52 0.7× 18 0.3× 14 0.3× 25 420

Countries citing papers authored by Daoyuan Si

Since Specialization
Citations

This map shows the geographic impact of Daoyuan Si's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daoyuan Si with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daoyuan Si more than expected).

Fields of papers citing papers by Daoyuan Si

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daoyuan Si. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daoyuan Si. The network helps show where Daoyuan Si may publish in the future.

Co-authorship network of co-authors of Daoyuan Si

This figure shows the co-authorship network connecting the top 25 collaborators of Daoyuan Si. A scholar is included among the top collaborators of Daoyuan Si based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daoyuan Si. Daoyuan Si is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peng, Kexin, Beibei Du, Daoyuan Si, et al.. (2024). IL-6 and D-dimer Levels at Admission Predict Cardiac Injury and Early Mortality during SARS-CoV-2 Infection. SHILAP Revista de lepidopterología. 9(1).
2.
Gao, Yi, Shuai Li, Xueyan Liu, et al.. (2024). RyR2 Stabilizer Attenuates Cardiac Hypertrophy by Downregulating TNF-α/NF-κB/NLRP3 Signaling Pathway through Inhibiting Calcineurin. Journal of Cardiovascular Translational Research. 17(3). 481–495. 4 indexed citations
3.
4.
Zhang, Zhongfan, Daoyuan Si, Qian Zhang, et al.. (2022). Prophylactic Rivaroxaban Therapy for Left Ventricular Thrombus After Anterior ST-Segment Elevation Myocardial Infarction. JACC: Cardiovascular Interventions. 15(8). 861–872. 26 indexed citations
5.
Dadson, Keith, Paaladinesh Thavendiranathan, Ludger Hauck, et al.. (2022). Statins Protect Against Early Stages of Doxorubicin-induced Cardiotoxicity Through the Regulation of Akt Signaling and SERCA2. CJC Open. 4(12). 1043–1052. 12 indexed citations
6.
Zhang, Qian, et al.. (2022). Rivaroxaban in heart failure patients with left ventricular thrombus: A retrospective study. Frontiers in Pharmacology. 13. 1008031–1008031. 9 indexed citations
7.
Jiang, Nan, Zhijun Li, Bo Yang, et al.. (2021). Peripheral Inflammatory Cytokines and Lymphocyte Subset Features of Deceased COVID‐19 Patients. BioMed Research International. 2021(1). 9101082–9101082. 8 indexed citations
8.
Zhang, Zhongfan, Daoyuan Si, Qian Zhang, et al.. (2021). Rivaroxaban versus Vitamin K Antagonists (warfarin) based on the triple therapy for left ventricular thrombus after ST-Elevation myocardial infarction. Heart and Vessels. 37(3). 374–384. 24 indexed citations
9.
Zhang, Qian, et al.. (2021). Loeffler endocarditis with intracardiac thrombus: case report and literature review. BMC Cardiovascular Disorders. 21(1). 615–615. 6 indexed citations
10.
Azam, Mohammed Ali, Praloy Chakraborty, Mahmoud Bokhari, et al.. (2021). Cardioprotective effects of dantrolene in doxorubicin-induced cardiomyopathy in mice. Heart Rhythm O2. 2(6). 733–741. 10 indexed citations
11.
Azam, Mohammed Ali, Praloy Chakraborty, Daoyuan Si, et al.. (2021). Anti-arrhythmic and inotropic effects of empagliflozin following myocardial ischemia. Life Sciences. 276. 119440–119440. 37 indexed citations
12.
Si, Daoyuan, Beibei Du, Bo Yang, et al.. (2020). Death, discharge and arrhythmias among patients with COVID-19 and cardiac injury. Canadian Medical Association Journal. 192(28). E791–E798. 42 indexed citations
13.
Du, Beibei, Praloy Chakraborty, Mohammed Ali Azam, et al.. (2020). Acute Effects of Ibrutinib on Ventricular Arrhythmia in Spontaneously Hypertensive Rats. JACC CardioOncology. 2(4). 614–629. 17 indexed citations
14.
15.
Si, Daoyuan, et al.. (2019). S-amlodipine improves endothelial dysfunction via the RANK/RANKL/OPG system by regulating microRNA-155 in hypertension. Biomedicine & Pharmacotherapy. 114. 108799–108799. 10 indexed citations
16.
Si, Daoyuan, et al.. (2018). A new technique to salvage myocardium following the failure of thrombus aspiration in acute myocardial infarction: a case report. BMC Cardiovascular Disorders. 18(1). 228–228. 2 indexed citations
17.
Si, Daoyuan, et al.. (2018). A new method for the assessment of endothelial function with peripheral arterial volume. BMC Cardiovascular Disorders. 18(1). 81–81. 6 indexed citations
18.
Si, Daoyuan, et al.. (2018). Rotational atherectomy ablation for an unexpandable stent under the guide of IVUS. Medicine. 97(7). e9978–e9978. 3 indexed citations
19.
Li, Jiayu, et al.. (2015). Global correlation analysis for microRNA and gene expression profiles in human obesity. Pathology - Research and Practice. 211(5). 361–368. 15 indexed citations
20.
He, Yuquan, et al.. (2013). The Effects of Amlodipine and S(-)-Amlodipine on Vascular Endothelial Function in Patients With Hypertension. American Journal of Hypertension. 27(1). 27–31. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun‐Yi Luo Breakdown of academic impact, for papers by Myoung Ju Koh Breakdown of academic impact, for papers by Shengda Hu Breakdown of academic impact, for papers by Yafeng Zhou Breakdown of academic impact, for papers by Christel H. Kamani Breakdown of academic impact, for papers by Xiaodong Jing Breakdown of academic impact, for papers by Jinru Wei Breakdown of academic impact, for papers by Yubi Lin Breakdown of academic impact, for papers by V. А. Snezhitskiy Breakdown of academic impact, for papers by Matthias Hammwöhner
Rankless by CCL
2026